aspect biosystems stock:Aspect Biosystems Named to Fast Company's 2023 List ...
Aspect Biosystems Named to Fast Company's 2023 List ...
2023年11月28日—Earlierthisyear,Aspectannouncedaprecedent-settingpartnershipwithNovoNordiskworthoverUS$2.6billiontodevelopbioprintedtissue ...。其他文章還包含有:「AspectBiosystemsStockPrice,Funding」、「AspectBiosystemsLtd」、「AspectBiosystemsCompanyProfile2024」、「Novo(NVO)&AspectBiosystemsUnitetoDevelopTissue...」、「AspectBiosystems」、「AspectBiosystemsAnnounces$200MillionPartnership......
查看更多 離開網站Aspect Biosystems Stock Price, Funding
https://www.cbinsights.com
Aspect Biosystems has raised $134.9M over 10 rounds. Aspect Biosystems's latest funding round was a Grant - IV for $53.36M on July 10, 2024.
Aspect Biosystems Ltd
https://www.bloomberg.com
Company profile page for Aspect Biosystems Ltd including stock price, company news, executives, board members, and contact information.
Aspect Biosystems Company Profile 2024
https://pitchbook.com
Information on valuation, funding, cap tables, investors, and executives for Aspect Biosystems. Use the PitchBook Platform to explore the full profile.
Novo (NVO) & Aspect Biosystems Unite to Develop Tissue ...
https://www.nasdaq.com
Novo Nordisk A/S NVO and a privately-held biotechnology company, Aspect Biosystems, announced entering a collaboration, development, and license agreement.
Aspect Biosystems
https://www.aspectbiosystems.c
Our transformative platform technology combines our proprietary bioprinting technology, therapeutic cells, biomaterials, and computational design.
Aspect Biosystems Announces $200 Million Partnership ...
https://finance.yahoo.com
The investment will support a $200 million, multi-year project to advance Aspect's unique clinical biomanufacturing capabilities.
Aspect Biosystems Receives Over $3.6 Million From the ...
https://www.aspectbiosystems.c
Aspect Biosystems, a biotechnology company pioneering the development of bioprinted tissue therapeutics, announced today that it has received over $3.6 million ...
Aspect Biosystems company information
https://app.dealroom.co
Aspect Biosystems, commercializing cutting-edge bioprinting technologies. Here you'll find information about their funding, investors and team.
Aspect Biosystems Secures $72.75 Million Government ...
https://www.synbiobeta.com
Aspect Biosystems has announced a $72.75 million investment from the Governments of Canada and British Columbia.